T. Nishida

Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene.

K. Harada, H. Yoshida, M. Sato, 1997, Cancer letters.

Immunoreactive Vasoactive Intestinal Polypeptide in Acinic Cell Carcinoma of the Parotid Gland

H. Yoshida, T. Nishida, Y. Hayashi, 1987, Cancer.

Peripheral Tγ lymphocyte population in head and neck cancer

H. Yoshida, M. Sato, T. Nishida, 2004, Cancer Immunology, Immunotherapy.

Immunohistochemical demonstration of carcinoembryonic antigen (CEA) on tissue sections from squamous cell head and neck cancer and plasma CEA levels of the patients.

H. Yoshida, M. Sato, T. Nishida, 1986, International journal of oral and maxillofacial surgery.

Peripheral k‐lymphocyte population in head and neck cancer

T. Nishida, Y. Yura, Mitsunobu Sato, 1984, Cancer.

Expression of vasoactive intestinal polypeptide and amylase in a human parotid gland adenocarcinoma cell line in culture.

H. Yoshida, M. Sato, T. Nishida, 1987, Journal of the National Cancer Institute.